Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Nucl Med Biol. 2011 Oct 26;39(1):137–144. doi: 10.1016/j.nucmedbio.2011.08.001

Table 3.

[18F]WC-II-89 vs [99mTc]mebrofenin uptake in anti-Fas antibody treated mice vs untreated controls

Ratio of Mean %ID/g in Treated vs Control Groups (Treated:Control Ratio)
[18F]WC-II-89 [99mTc]Mebrofenin
30 min 60 min 30 min 60 min


Blood 1.8 2.9* 1.5* 1.5
Bone 1.3 1.3 1.7* 1.3
Fat 1.1 2.1 1.2 1.3
Heart 1.6* 2.1* 1.3* 1.1
Kidney 2.2 4.8* 1.5 1.7
Liver 3.4* 2.3* 7.6 2.0
Lung 1.8* 2.2* 1.6 1.7
Muscle 1.6* 0.6 2.1 0.2
Spleen 1.8* 1.9* 1.5 1.7
Thymus 1.3 1.8 0.8 1.2

N=4 in all groups.

%ID/g = Percent injected dose per gram of tissue

*

p<0.05 when comparing the mean %ID/g of the treated vs untreated control groups for each tracer

p<0.10 when comparing the mean %ID/g of the treated vs untreated control groups for each tracer

Analysis for blood excludes one data point in the control group deemed contaminated (17 %ID/g vs 1.4±0.15 %ID/G for remaining 3 values in the control group for blood; %ID/g for blood from untreated controls in prior experiments was 0.8±0.1, N=4, Table 2). The treated:control ratio for the control blood including the high outlier was 0.77. The p-value was not significant if this outlier was included in the analysis.